(1 - 11 von 13
)
Armed antibodies for cancer immunotherapy: DKFZ and DKTK scientists...
www.dkfz.de
"Cytokines are toxic in larger quantities and activation is unfortunately nonspecific if they are fused to antibodies in the blood without being attached to the tumor," explained DKTK Professor and physician Helmut Salih, head of the Clinical Cooperation Unit Translational Immunology at Tübingen University Hospital.
Making cancer stem cells visible to the immune system
www.bionity.com
"An essential mechanism of this immune resistance in leukemia stem cells is apparently the suppression of danger signals such as NKG2D-L on the cell surface," added Helmut Salih from the University Hospital of Tübingen and the German Cancer Consortium DKTK. What is behind this extraordinary protective mechanism?
SYNIMMUNE GmbH Reports Interim Results of First-in-Human ...
www.dgap.de
The preliminary efficacy data are promising. We are very much looking forward to further test FLYSYN as monotherapy for MRD positive AML patients," commented Prof. Helmut Salih, Principle Investigator of the study and Medical Director of the Clinical Collaboration Unit Translational Immunology at Tübingen University Hospital.
Making cancer stem cells visible to the immune system | Stem ...stemcellsportal.com › news › making-cancer-ste...
stemcellsportal.com
... the suppression of danger signals such as NKG2D-L on the cell surface," added Helmut Salih, M.D., from the University Hospital of Tübingen ...
sortiert nach Relevanz / Datum